MoneyWorks4Me

Shilpa Medicare - Quaterly Results

06 Aug 2026 Evaluate
The Total revenue for the quarter ended June 2026 of  Rs. 1890.40 millions grew by 102.27% from Rs. 934.60 millions.The Total revenue for the quarter ended June 2026 of  Rs. 649.20  millions  grew by 246.98% from Rs. 187.10 millions.Operating profit surged to 655.70 millions from the corresponding previous quarter of 328.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1890.40 934.60 102.27 1890.40 934.60 102.27 5970.30 4774.10 25.06
Other Income 95.60 130.20 -26.57 95.60 130.20 -26.57 381.40 696.70 -45.26
PBIDT 655.70 328.60 99.54 655.70 328.60 99.54 1938.60 2058.00 -5.80
Interest 25.30 22.30 13.45 25.30 22.30 13.45 100.40 58.70 71.04
PBDT 665.50 254.50 161.49 665.50 254.50 161.49 2032.40 1541.90 31.81
Depreciation 154.90 130.60 18.61 154.90 130.60 18.61 551.10 488.60 12.79
PBT 510.60 123.90 312.11 510.60 123.90 312.11 1481.30 1053.30 40.63
TAX -138.60 -63.20 119.30 -138.60 -63.20 119.30 151.60 374.40 -59.51
Deferred Tax -276.40 44.20 -725.34 -276.40 44.20 -725.34 76.60 -96.40 -179.46
PAT 649.20 187.10 246.98 649.20 187.10 246.98 1329.70 678.90 95.86
Equity 195.60 97.80 100.00 195.60 97.80 100.00 195.60 97.80 100.00
PBIDTM(%) 34.69 35.16 -1.35 34.69 35.16 -1.35 32.47 43.11 -24.68

Shilpa Medicare Share Price

759.60 19.55 (2.64%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: